News Clinical Trials

FDA Explores AI to Accelerate Early-Phase Clinical Trials in Pilot Program

May 06, 2026 By ASCO AI Staff 2 min read
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter
Top Thought Leaders in Topic Area

Topic Name

ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.

KOL Commentary
Watch

Related Content